These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
375 related items for PubMed ID: 33555272
1. RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia. Matthijssens F, Sharma ND, Nysus M, Nickl CK, Kang H, Perez DR, Lintermans B, Van Loocke W, Roels J, Peirs S, Demoen L, Pieters T, Reunes L, Lammens T, De Moerloose B, Van Nieuwerburgh F, Deforce DL, Cheung LC, Kotecha RS, Risseeuw MD, Van Calenbergh S, Takarada T, Yoneda Y, van Delft FW, Lock RB, Merkley SD, Chigaev A, Sklar LA, Mullighan CG, Loh ML, Winter SS, Hunger SP, Goossens S, Castillo EF, Ornatowski W, Van Vlierberghe P, Matlawska-Wasowska K. J Clin Invest; 2021 Mar 15; 131(6):. PubMed ID: 33555272 [Abstract] [Full Text] [Related]
2. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory. Peterson JF, Baughn LB, Pearce KE, Williamson CM, Benevides Demasi JC, Olson RM, Goble TA, Meyer RG, Greipp PT, Ketterling RP. Genes Chromosomes Cancer; 2018 Nov 15; 57(11):541-546. PubMed ID: 30203571 [Abstract] [Full Text] [Related]
3. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia. Blackburn PR, Smadbeck JB, Znoyko I, Webley MR, Pitel BA, Vasmatzis G, Xu X, Greipp PT, Hoppman NL, Ketterling RP, Baughn LB, Lindsey KG, Schandl CA, Wolff DJ, Peterson JF. Genes Chromosomes Cancer; 2020 Jul 15; 59(7):422-427. PubMed ID: 32196814 [Abstract] [Full Text] [Related]
4. Rare KMT2A-ELL and Novel ZNF56-KMT2A Fusion Genes in Pediatric T-cell Acute Lymphoblastic Leukemia. Panagopoulos I, Andersen K, Eilert-Olsen M, Rognlien AG, Munthe-Kaas MC, Micci F, Heim S. Cancer Genomics Proteomics; 2021 Jul 15; 18(2):121-131. PubMed ID: 33608309 [Abstract] [Full Text] [Related]
5. Rearrangements of ATP5L-KMT2A in acute lymphoblastic leukaemia. Ferrari A, Ghelli Luserna Di Rora A, Domizio C, Papayannidis C, Simonetti G, Maria Hernández-Rivas J, Rondoni M, Giglio F, Abruzzese E, Imovilli A, Iacobucci I, Calistri D, Martinelli G. Br J Haematol; 2021 Mar 15; 192(6):e139-e144. PubMed ID: 33314053 [No Abstract] [Full Text] [Related]
11. A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells. Oo ZM, Illendula A, Grembecka J, Schmidt C, Zhou Y, Esain V, Kwan W, Frost I, North TE, Rajewski RA, Speck NA, Bushweller JH. Leuk Lymphoma; 2018 Sep 15; 59(9):2188-2200. PubMed ID: 29249175 [Abstract] [Full Text] [Related]
12. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A. Bill M, Mrózek K, Kohlschmidt J, Eisfeld AK, Walker CJ, Nicolet D, Papaioannou D, Blachly JS, Orwick S, Carroll AJ, Kolitz JE, Powell BL, Stone RM, de la Chapelle A, Byrd JC, Bloomfield CD. Proc Natl Acad Sci U S A; 2020 Oct 20; 117(42):26340-26346. PubMed ID: 33020282 [Abstract] [Full Text] [Related]
13. [Methylation of CpG island in promoter region of RUNX2 gene and its expression in HOX11(+) acute T lymphoblastic leukemia]. Jia JS, Salvatore S. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr 20; 21(2):273-8. PubMed ID: 23628015 [Abstract] [Full Text] [Related]
14. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia. Tsagarakis NJ, Papadhimitriou SI, Pavlidis D, Marinakis T, Kostopoulos IV, Stiakaki E, Polychronopoulou S, Paterakis G. Int J Lab Hematol; 2019 Jun 20; 41(3):364-372. PubMed ID: 30730614 [Abstract] [Full Text] [Related]
15. Therapy-induced Deletion in 11q23 Leading to Fusion of KMT2A With ARHGEF12 and Development of B Lineage Acute Lymphoplastic Leukemia in a Child Treated for Acute Myeloid Leukemia Caused by t(9;11)(p21;q23)/KMT2A-MLLT3. Panagopoulos I, Andersen K, Eilert-Olsen M, Zeller B, Munthe-Kaas MC, Buechner J, Osnes LTN, Micci F, Heim S. Cancer Genomics Proteomics; 2021 Jun 20; 18(1):67-81. PubMed ID: 33419897 [Abstract] [Full Text] [Related]
16. MLL/KMT2A translocations in diffuse large B-cell lymphomas. Gindin T, Murty V, Alobeid B, Bhagat G. Hematol Oncol; 2015 Dec 20; 33(4):239-46. PubMed ID: 25131304 [Abstract] [Full Text] [Related]
17. Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia. Sharma ND, Nickl CK, Kang H, Ornatowski W, Brown R, Ness SA, Loh ML, Mullighan CG, Winter SS, Hunger SP, Cannon JL, Matlawska-Wasowska K. Cancer Sci; 2019 Jun 20; 110(6):1931-1946. PubMed ID: 30974024 [Abstract] [Full Text] [Related]
18. First case of B ALL with KMT2A-MAML2 rearrangement: a case report. Menu E, Beaufils N, Usseglio F, Balducci E, Lafage Pochitaloff M, Costello R, Gabert J. BMC Cancer; 2017 May 23; 17(1):363. PubMed ID: 28535805 [Abstract] [Full Text] [Related]
19. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory. Peterson JF, Sukov WR, Pitel BA, Smoley SA, Pearce KE, Meyer RG, Williamson CM, Smadbeck JB, Vasmatzis G, Hoppman NL, Greipp PT, Baughn LB, Ketterling RP. Genes Chromosomes Cancer; 2019 Aug 23; 58(8):567-577. PubMed ID: 30707474 [Abstract] [Full Text] [Related]